Revolution Medicines logo

Revolution Medicines Share Price (NASDAQ: RVMD)

$37.01

0.53

(1.45%)

Last updated on

Check the interactive Revolution Medicines Stock chart to analyse performance

Revolution Medicines stock performance

as on August 23, 2025 at 1:29 AM IST

  • Today's Low:$36.59
    Today's High:$37.87

    Day's Volatility :3.39%

  • 52 Weeks Low:$29.17
    52 Weeks High:$62.40

    52 Weeks Volatility :53.25%

Revolution Medicines Stock Returns

PeriodRevolution Medicines IncSector (Health Care)Index (Russel 2000)
3 Months
0.09%
6.0%
0.0%
6 Months
-10.24%
-6.4%
0.0%
1 Year
-16.0%
-11.1%
0.0%
3 Years
62.32%
6.7%
-8.6%

Revolution Medicines Inc Key Stats

Check Revolution Medicines key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$36.48
Open
$36.585
Today's High
$37.87
Today's Low
$36.585
Market Capitalization
$6.8B
Today's Volume
$1.1M
52 Week High
$62.4
52 Week Low
$29.17
Revenue TTM
$742.0K
EBITDA
$-890.7M
Earnings Per Share (EPS)
$-4.52
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-46.61%

Stock Returns calculator for Revolution Medicines Stock including INR - Dollar returns

The Revolution Medicines stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Revolution Medicines investment value today

Current value as on today

₹88,315

Returns

₹11,685

(-11.69%)

Returns from Revolution Medicines Stock

₹16,001 (-16%)

Dollar Returns*

₹4,316 (+4.32%)

Indian investors sentiment towards Revolution Medicines Stock

-17%

Period: Jul 25, 2025 to Aug 24, 2025. Change in 30 Days versus previous period

Search interest for Revolution Medicines Stock from India on INDmoney has decreased by -17% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Revolution Medicines Inc

  • Name

    Holdings %

  • Vanguard Group Inc

    8.43%

  • BlackRock Inc

    7.86%

  • Farallon Capital Management, L.L.C.

    7.24%

  • HHG PLC

    5.67%

  • Wellington Management Company LLP

    5.49%

  • Baker Bros Advisors LP

    4.25%

Analyst Recommendation on Revolution Medicines Stock

Rating
Trend

Buy

    94%Buy

    5%Hold

    0%Sell

Based on 19 Wall street analysts offering stock ratings for Revolution Medicines(by analysts ranked 0 to 5 stars)

Revolution Medicines Share Price Target

What analysts predicted

Upside of 95.62%

Target:

$72.40

Current:

$37.01

Revolution Medicines share price target is $72.40, a slight Upside of 95.62% compared to current price of $37.01 as per analysts' prediction.

Revolution Medicines Stock Insights

  • Price Movement

    In the last 3 months, RVMD stock has moved down by -6.9%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, 742.0K → 261.59M (in $), with an average increase of 99.7% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 6 quarters, -116.00M → -247.78M (in $), with an average decrease of 16.5% per quarter
  • RVMD vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.6% return, outperforming this stock by 81.8%
  • RVMD vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 105.6% return, outperforming this stock by 46.3%
  • Price to Sales

    ForRVMD every $1 of sales, investors are willing to pay $7402.0, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.9 for every $1 of sales.

Revolution Medicines Technicals Summary

Sell

Neutral

Buy

Revolution Medicines is currently in a neutral trading position according to technical analysis indicators.

Revolution Medicines Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Revolution Medicines Inc logo
-2.36%
-10.24%
-16.0%
62.32%
31.24%
Regeneron Pharmaceuticals, Inc. logo
4.66%
-17.37%
-50.86%
-2.39%
-3.46%
Beone Medicines Ltd logo
7.62%
21.35%
57.45%
78.28%
25.05%
Vertex Pharmaceuticals Incorporated logo
-15.87%
-17.97%
-18.14%
35.67%
45.07%
Alnylam Pharmaceuticals, Inc. logo
38.16%
82.49%
68.79%
112.36%
238.79%

Revolution Medicines Dividend announcements

  • Revolution Medicines Earnings

    Revolution Medicines’s price-to-earnings ratio stands at None

About Revolution Medicines Inc

Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline consist of RAS(ON) inhibitors that binds RAS variants to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors to suppress cooperating targets and pathways that sustain RAS-addicted cancers. Its RAS(ON) inhibitors include daraxonrasib (RMC-6236), elironrasib G12C (RMC-6291), and zoldonrasib G12D (RMC-9805), which are in phase 1 clinical trial; and development candidates comprise RMC-5127 (G12V), RMC-0708 (Q61H), and RMC-8839 (G13C). The company's RAS companion inhibitors include RMC-4630 that is in phase 2 clinical trial; RMC-5552, a selective inhibitor of mTORC1 signaling in tumors, which is in phase 1 clinical trial; and RMC-5845 that targets SOS1. Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.
Organization
Revolution Medicines
Employees
700
CEO
Dr. Mark A. Goldsmith M.D., Ph.D.
Industry
Health Technology

Key Management of Revolution Medicines Inc

NameTitle
Dr. Mark A. Goldsmith M.D., Ph.D.
CEO, President & Chairman
Mr. Jack Anders
Chief Financial Officer
Ms. Margaret A. Horn J.D.
Chief Operating Officer
Dr. Stephen M. Kelsey FRC Path., FRCP, M.D.
President of Research & Development
Ms. Xiaolin Wang
Executive Vice President of Development
Dr. Martin D. Burke M.D., Ph.D.
Co-Founder & Chairman of Scientific Advisory Board
Dr. Michael A. Fischbach Ph.D.
Academic Co-Founder & Member of Scientific Advisory Board
Dr. Kevan M. Shokat Ph.D.
Academic Co-Founder & Member of Scientific Advisory Board
Mr. Walter Reiher Ph.D.
Chief Information Officer
Ms. Jan Smith Ph.D.
Chief Scientific Officer

Important FAQs about investing in RVMD Stock from India :

What is Revolution Medicines share price today?

Revolution Medicines share price today is $37.01 as on at the close of the market. Revolution Medicines share today touched a day high of $37.87 and a low of $36.59.

What is the 52 week high and 52 week low for Revolution Medicines share?

Revolution Medicines share touched a 52 week high of $62.40 and a 52 week low of $29.17. Revolution Medicines stock price today i.e. is closed at $37.01, lower by 40.69% versus the 52 week high.

How to invest in Revolution Medicines Stock (RVMD) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Revolution Medicines on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Revolution Medicines Shares that will get you 0.0405 shares as per Revolution Medicines share price of $37.01 per share as on August 23, 2025 at 1:29 AM IST.

What is the minimum amount required to buy Revolution Medicines Stock (RVMD) from India?

Indian investors can start investing in Revolution Medicines (RVMD) shares with as little as ₹87.521 or $1 (as of August 25, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹875.21 in Revolution Medicines stock (as per the Rupee-Dollar exchange rate as on August 25, 2025). Based on Revolution Medicines share’s latest price of $37.01 as on August 23, 2025 at 1:29 AM IST, you will get 0.2702 shares of Revolution Medicines. Learn more about fractional shares .

What are the returns that Revolution Medicines has given to Indian investors in the last 5 years?

Revolution Medicines stock has given 31.24% share price returns and 18.0% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?